The Washington Times
  • Subscribe
  • Times News Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out
  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Customer Service
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Other
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
  • Marketplace
    • Autos
    • Jobs
    • Real Estate
    • Classifieds
    • Shopping
    • Dining Out
    • Education
    • TWT Store
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
    • Joe Giganti
    • Video Game Minute
  • Podcasts
    • About Headlines
    • Audio and Radio
    • America's Morning News
  • Local

    Court refuses to halt sniper's execution

  • National

    DAVIS: Yankee hater finds love for team

  • National

    Gulf Coast preps as Ida weakens to tropical storm

  • Politics

    Abortion a main issue in health debate

  • Sports

    Redskins still going south

  • World

    Ex-Soviet Union struggles with democracy

  • Politics

    Health bill faces roadblocks in Senate

Home » News » Editor Favorites

Wednesday, July 9, 2008

Principi prodded VA on Chantix

Rate this story

Average 0.00
after 0 votes
Login or register to rate this story

Ex-secretary asked if use would continue

  • Font Size -+
  • Print
  • Email
  • Comment
  • Tweet this!
  • Share
  • Article
  • Comments ()
  • Click-2-Listen
  • Videos
Please stand by, images loading!
  • Anthony J. Principi forwarded inquiries from Pfizer about Chantix's status on the Department of Veterans Affairs' list of prescribed drugs.

More Editor Favorites Stories

  • Court refuses to halt sniper's execution
  • DAVIS: Yankee hater finds love for team
  • Gulf Coast preps as Ida weakens to tropical storm
  • Abortion a main issue in health debate

By Audrey Hudson and Jen Haberkorn

EXCLUSIVE: Former Veterans Affairs Secretary Anthony J. Principi contacted colleagues at his old agency as the chief lobbyist for drug maker Pfizer Inc. earlier this year, looking for updates on whether his company's smoking-cessation drug Chantix would remain on the VA's list of approved prescription drugs amid new warnings of dangerous side effects.

The government had just banned Chantix for use by pilots and air traffic controllers because of potential side effects on alertness and motor skills and had more broadly warned that the medicine could cause depression, suicidal thoughts and attempted suicide. Pfizer wanted insight on the VA's intent for the drug, which has been prescribed to thousands of veterans.

Pfizer officials maintain that Mr. Principi's contacts at his old agency did not amount to lobbying and that all he did was pass along requests via e-mail asking whether an internal study that examined 27 veterans hospitalized for psychotic episodes while taking Chantix would be made public.

E-mails reviewed by The Washington Times also reveal that Mr. Principi forwarded inquiries from Pfizer about Chantix's status on the VA's list of prescribed drugs, at one point stating, "I really hate to be a pain, but I keep getting asked these questions."

Mr. Principi's private work after serving as President Bush's first VA secretary from 2001 though early 2005 provides what ethics analysts say is a textbook case of the "revolving door," in which former Cabinet secretaries, powerful lawmakers and well-connected regulators land lucrative jobs helping corporate America influence federal policy and decisions by their former colleagues. The practice is legal, but frequently raises concerns about the appearance of conflicts of interest.

The Clinton administration addressed the issue with a sweeping order that banned top officials from lobbying the government until five years after they left public service for the private sector.

But President Clinton ended that five-year ban just before he left office, in January 2001. The Bush administration then reverted to the one-year ban that was enacted as part of the Ethics Reform Act of 1989. Congress in 2007 increased the waiting period to two years, but by that time it did not apply to Mr. Principi.

Mr. Principi declined to be quoted for this story, including answering whether he began interviewing for the Pfizer job while he was still VA secretary in 2004.

But his company's dealings with the VA have taken on new importance as Congress investigates why the veterans agency took months to alert its patients about Chantix's new side effects, such as suicide and psychosis, even when it knew veterans suffering from post-traumatic stress disorder (PTSD) were among those taking the drug.

The first hearings, prompted by a series of stories in The Times over the past month, is set to open today before the House Veterans' Affairs Committee.

[Get Copyright Permissions] Click here for reprint permissions!
Copyright 2009 The Washington Times, LLC

12Next »

Post a comment

There are comments on this article, submit your opinion!

Please login or register to post a comment

Ask a Question

You Report

Do you have another point of view, photos, audio, video or more information about a story?

Top Stories

Most Read

  1. EXCLUSIVE: Rare virus poses new threat to troops
  2. KELLNER: New Apple mouse really is 'Magic'
  3. Parents buying homes for kids at college
  4. EDITORIAL: Too scared to recognize terrorism
  5. Deer dies after leap into D.C. zoo lion exhibit
More Top Stories »
  1. Federal Reserve opposed as big bank savior by odd allies
  2. Court refuses to halt sniper's execution
  3. House OKs health reform bill
  4. Annandale man killed in hit-and-run
  5. Inside the Beltway

Most Shared

  1. KELLNER: New Apple mouse really is 'Magic'
  2. Deer dies after leap into D.C. zoo lion exhibit
  3. EDITORIAL: Too scared to recognize terrorism
  4. EXCLUSIVE: Rare virus poses new threat to troops
  5. Parents buying homes for kids at college
More Top Stories »
  1. EDITORIAL: President Obama causes more unemployment
  2. The enemy at home
  3. Federal Reserve opposed as big bank savior by odd allies
  4. Patent case goes to Supreme Court
  5. After the Berlin Wall: German unity proves elusive

Most Commented

  1. House OKs health reform bill
  2. EDITORIAL: Too scared to recognize terrorism
  3. Army chief wary of backlash against Muslim soldiers
  4. EDITORIAL: Mr. Obama, stay away from this wall
  5. Health bill faces roadblocks in Senate
More Top Stories »
  1. Lieberman vows probe of Hood rampage
  2. Suspected Fort Hood shooter is awake, talking
  3. Obama: It's Senate's turn on health care
  4. EDITORIAL: President Obama causes more unemployment
  5. The enemy at home

Listen to Washington Times Radio

  • America's Morning News

    with John McCaslin and Melanie Morgan

Question of the day

White House officials and Senate Democrats met in private three times last week to craft health care legislation. Do you think these discussions should be more public?

Blogs & Columns

  • POTUS Notes

    New Dem talking point on Obama approval doesn't wash

  • The Back Story

    12 arrested at Pelosi's office

  • Belief Blog

    New Vatican constitution released

  • Out of Context

    Foods that might kill libido

  • Technology

    Facebook wins round against phishing spammer

  • On the Fly

    United lifts some 'award' blocking

  • Redskins 360

    No interest in Johnson

  • Tara's Two Cents

    On their way to summer vacation..

  • SNOBlog

    Beyond 'Woody'

Videos

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.